iPath, Inc. – Trademark Portfolio
Entity Type: 03
iPath, Inc. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 3 (Cosmetics & Cleaning) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 5 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include KSTECHNIQUE. The owner is based in New York, NY.
136 W16th Street
Apt. 1RE
New York, NY 10011
Showing of trademarks Trademarks
Trademark Classifications
iPath, Inc.'s trademark portfolio spans 5 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Scientific and technological services; industrial analysis and research services
Advertising; business management; business administration; office functions
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does iPath, Inc. have?
iPath, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 1 registered, 2 abandoned, 3 cancelled.
What trademark classes does iPath, Inc. file in?
iPath, Inc. files trademarks across 5 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 42 (Computer & Scientific), Class 35 (Advertising & Business), Class 41 (Education & Entertainment), Class 14 (Jewelry). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.
What are iPath, Inc.'s most well-known trademarks?
iPath, Inc.'s registered trademark portfolio includes well-known marks such as KSTECHNIQUE. These are among 1 currently registered trademark in the portfolio.
What is iPath, Inc.'s trademark registration success rate?
iPath, Inc. has a 17% trademark registration rate, with 1 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.